BRCA1 and ovarian carcinoma: The aim of this study was to identify a novel lncRNA prognostic biomarker to provide potentially new and accurate biological indicators for the early diagnosis and monitoring of prognosis of ovarian cancer bearing BRCA1/2 mutations.